Colorectal cancer represents 8.3 percent of all new cancer diagnoses in the U.S. In 2016, there were an estimated 1,324,922 people in the U.S. living with colorectal cancer. It is the second-leading cause of cancer death in the U.S., accounting for 8.4 percent of all cancer deaths.
The rate of new colorectal cancer cases has been falling an average of 2.4 percent each year over the last 10 years. Death rates fell an average of 2.2 percent each year between 2007 and 2016. Depending on whether and how much the cancer has spread, colorectal cancer is most often treated with radiation, chemotherapy, or surgery.
Source: NIH National Cancer Institute, Cancer Stat Facts: Colorectal Cancer
To support quality improvement (QI) projects in mCRC (metastatic colorectal cancer), the Association of Community Cancer Centers (ACCC) has partnered with Pfizer Global Medical Grants to award more than $1 million in funding to QI projects that are aimed at improving the integration of biomarker testing in personalized treatment selection for patients with mCRC.
Innovations in Colorectal Cancer Treatment ECHO Clinic
ACCC is committed to help ensure access to recommended care for patients who receive treatment for colorectal cancer through a partnership with the American Cancer Society and Project ECHO. Project ECHO was developed more than a decade ago at the University of New Mexico Health Sciences Center to improve access to care for complex chronic health conditions through virtual education and training of local providers who wish to improve their skills in treating complex health conditions.
This program provides specialty colorectal cancer treatment information and training to healthcare providers to help build their capacity to provide high-quality, best-practice care locally for patients and thereby increase access to care across the nation.